Question · asked by 1 review
Naproxen vs placebo: Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale)
- Population
- Not specified
- Intervention
- Naproxen
- Comparison
- placebo
- Outcome
- Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale)
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Naproxen vs placebo Daily pain relief score (6‐point scale) Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 33 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Naproxen vs placebo · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD… · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.